These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 26708047)
21. Distinct Immunological Landscapes Characterize Inherited and Sporadic Mismatch Repair Deficient Endometrial Cancer. Ramchander NC; Ryan NAJ; Walker TDJ; Harries L; Bolton J; Bosse T; Evans DG; Crosbie EJ Front Immunol; 2019; 10():3023. PubMed ID: 31998307 [TBL] [Abstract][Full Text] [Related]
22. Analysis of mismatch repair gene mutations in Turkish HNPCC patients. Tunca B; Pedroni M; Cecener G; Egeli U; Borsi E; Zorluoglu A; Di Gregorio C; Yilmazlar T; Yerci O; de Leon MP Fam Cancer; 2010 Sep; 9(3):365-76. PubMed ID: 20373145 [TBL] [Abstract][Full Text] [Related]
23. The mechanism of mismatch repair and the functional analysis of mismatch repair defects in Lynch syndrome. Martín-López JV; Fishel R Fam Cancer; 2013 Jun; 12(2):159-68. PubMed ID: 23572416 [TBL] [Abstract][Full Text] [Related]
24. Distinct effects of the recurrent Mlh1G67R mutation on MMR functions, cancer, and meiosis. Avdievich E; Reiss C; Scherer SJ; Zhang Y; Maier SM; Jin B; Hou H; Rosenwald A; Riedmiller H; Kucherlapati R; Cohen PE; Edelmann W; Kneitz B Proc Natl Acad Sci U S A; 2008 Mar; 105(11):4247-52. PubMed ID: 18337503 [TBL] [Abstract][Full Text] [Related]
25. Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing. Buchanan DD; Tan YY; Walsh MD; Clendenning M; Metcalf AM; Ferguson K; Arnold ST; Thompson BA; Lose FA; Parsons MT; Walters RJ; Pearson SA; Cummings M; Oehler MK; Blomfield PB; Quinn MA; Kirk JA; Stewart CJ; Obermair A; Young JP; Webb PM; Spurdle AB J Clin Oncol; 2014 Jan; 32(2):90-100. PubMed ID: 24323032 [TBL] [Abstract][Full Text] [Related]
26. Constitutional Mismatch Repair Deficiency in Israel: High Proportion of Founder Mutations in MMR Genes and Consanguinity. Baris HN; Barnes-Kedar I; Toledano H; Halpern M; Hershkovitz D; Lossos A; Lerer I; Peretz T; Kariv R; Cohen S; Half EE; Magal N; Drasinover V; Wimmer K; Goldberg Y; Bercovich D; Levi Z Pediatr Blood Cancer; 2016 Mar; 63(3):418-27. PubMed ID: 26544533 [TBL] [Abstract][Full Text] [Related]
27. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer. Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847 [TBL] [Abstract][Full Text] [Related]
28. Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome. Gargiulo S; Torrini M; Ollila S; Nasti S; Pastorino L; Cusano R; Bonelli L; Battistuzzi L; Mastracci L; Bruno W; Savarino V; Sciallero S; Borgonovo G; Nyström M; Bianchi-Scarrà G; Mareni C; Ghiorzo P Fam Cancer; 2009; 8(4):547-53. PubMed ID: 19728162 [TBL] [Abstract][Full Text] [Related]
30. Mismatch repair genes founder mutations and cancer susceptibility in Lynch syndrome. Ponti G; Castellsagué E; Ruini C; Percesepe A; Tomasi A Clin Genet; 2015 Jun; 87(6):507-16. PubMed ID: 25345868 [TBL] [Abstract][Full Text] [Related]
31. Evaluating the performance of clinical criteria for predicting mismatch repair gene mutations in Lynch syndrome: a comprehensive analysis of 3,671 families. Steinke V; Holzapfel S; Loeffler M; Holinski-Feder E; Morak M; Schackert HK; Görgens H; Pox C; Royer-Pokora B; von Knebel-Doeberitz M; Büttner R; Propping P; Engel C; Int J Cancer; 2014 Jul; 135(1):69-77. PubMed ID: 24493211 [TBL] [Abstract][Full Text] [Related]
32. [Correlation between mismatch-repair protein expression and clinicopathologic features in 658 colorectal cancers]. Hu XR; Xu C; Kang Y; Wang T; Zhang Y; Yang XH Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):827-833. PubMed ID: 30423605 [No Abstract] [Full Text] [Related]
33. Functional analysis of MSH2 unclassified variants found in suspected Lynch syndrome patients reveals pathogenicity due to attenuated mismatch repair. Wielders EA; Hettinger J; Dekker R; Kets CM; Ligtenberg MJ; Mensenkamp AR; van den Ouweland AM; Prins J; Wagner A; Dinjens WN; Dubbink HJ; van Hest LP; Menko F; Hogervorst F; Verhoef S; te Riele H J Med Genet; 2014 Apr; 51(4):245-53. PubMed ID: 24501230 [TBL] [Abstract][Full Text] [Related]
34. Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome. Guindalini RS; Win AK; Gulden C; Lindor NM; Newcomb PA; Haile RW; Raymond V; Stoffel E; Hall M; Llor X; Ukaegbu CI; Solomon I; Weitzel J; Kalady M; Blanco A; Terdiman J; Shuttlesworth GA; Lynch PM; Hampel H; Lynch HT; Jenkins MA; Olopade OI; Kupfer SS Gastroenterology; 2015 Nov; 149(6):1446-53. PubMed ID: 26248088 [TBL] [Abstract][Full Text] [Related]
35. Induction of mismatch repair deficiency, compromised DNA damage signaling and compound hypermutagenesis by a dietary mutagen in a cell-based model for Lynch syndrome. Ijsselsteijn R; van Hees S; Drost M; Jansen JG; de Wind N Carcinogenesis; 2022 Mar; 43(2):160-169. PubMed ID: 34919656 [TBL] [Abstract][Full Text] [Related]
36. The coding microsatellite mutation profile of PMS2-deficient colorectal cancer. Bajwa-Ten Broeke SW; Ballhausen A; Ahadova A; Suerink M; Bohaumilitzky L; Seidler F; Morreau H; van Wezel T; Krzykalla J; Benner A; de Miranda NF; von Knebel Doeberitz M; Nielsen M; Kloor M Exp Mol Pathol; 2021 Oct; 122():104668. PubMed ID: 34302852 [TBL] [Abstract][Full Text] [Related]
37. A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome. Walker R; Mahmood K; Joo JE; Clendenning M; Georgeson P; Como J; Joseland S; Preston SG; Antill Y; Austin R; Boussioutas A; Bowman M; Burke J; Campbell A; Daneshvar S; Edwards E; Gleeson M; Goodwin A; Harris MT; Henderson A; Higgins M; Hopper JL; Hutchinson RA; Ip E; Isbister J; Kasem K; Marfan H; Milnes D; Ng A; Nichols C; O'Connell S; Pachter N; Pope BJ; Poplawski N; Ragunathan A; Smyth C; Spigelman A; Storey K; Susman R; Taylor JA; Warwick L; Wilding M; Williams R; Win AK; Walsh MD; Macrae FA; Jenkins MA; Rosty C; Winship IM; Buchanan DD; J Transl Med; 2023 Apr; 21(1):282. PubMed ID: 37101184 [TBL] [Abstract][Full Text] [Related]
38. Screening for germline mismatch repair mutations following diagnosis of sebaceous neoplasm. Everett JN; Raymond VM; Dandapani M; Marvin M; Kohlmann W; Chittenden A; Koeppe E; Gustafson SL; Else T; Fullen DR; Johnson TM; Syngal S; Gruber SB; Stoffel EM JAMA Dermatol; 2014 Dec; 150(12):1315-21. PubMed ID: 25006859 [TBL] [Abstract][Full Text] [Related]
39. Epigenetic mechanisms in the pathogenesis of Lynch syndrome. Peltomäki P Clin Genet; 2014 May; 85(5):403-12. PubMed ID: 24443998 [TBL] [Abstract][Full Text] [Related]
40. Identification of novel pathogenic MSH2 mutation and new DNA repair genes variants: investigation of a Tunisian Lynch syndrome family with discordant twins. Jaballah-Gabteni A; Tounsi H; Kabbage M; Hamdi Y; Elouej S; Ben Ayed I; Medhioub M; Mahmoudi M; Dallali H; Yaiche H; Ben Jemii N; Maaloul A; Mezghani N; Abdelhak S; Hamzaoui L; Azzouz M; Boubaker S J Transl Med; 2019 Jun; 17(1):212. PubMed ID: 31248416 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]